Redica Systems

Trends

Update: What are Pharma and Med Device Firms Doing About COVID-19?

March 11, 2020

Enforcement

Warning Letters Week of 3/1/2020: Device Design Controls

March 10, 2020

Enforcement

FDA Warning Letters Week of 2/23/2020: After 3-Week Absence, 8 to Drug and Device Firms

March 3, 2020

Enforcement

The Importance of Monitoring Import Alerts

February 26, 2020

Conference Spotlight

Part 2: Department of Justice Consumer Protection Branch Doubles in Size to Battle Fraud and Deception in the Drug and Dietary Supplement Industries

February 25, 2020

January 483s: Most Popular and Newsworthy

February 13, 2020

Enforcement

FDA Warning Letters Week of 2/2/2020: Device Repeat Deficiencies

February 11, 2020

Enforcement

FDA Warning Letters Week of 1/26/2020: HCT/P and OTC Products

February 4, 2020

GMP Compliance for Legacy Products: How to Find and Avoid Potential Quality Issues

January 30, 2020

510k – What is the FDA 510(k) Premarket Notification?

January 24, 2020

Enforcement

FDA Warning Letters Week of 1/12/2020: CMO Quality

January 21, 2020

December 483s: Most Popular and Newsworthy

January 15, 2020

Enforcement

Warning Letters Week of 1/5/2020: Data Discrepancies

January 14, 2020

Conference Spotlight

How to Talk So That FDA Will Listen, and How to Listen When They Talk: Advice That Could Be Worth Millions

January 10, 2020

November 483s: Most Popular and Newsworthy

December 27, 2019

Enforcement

FDA Warning Letters Week of 12/15/2019: Independent Assessment Requests

December 23, 2019

Enforcement

FDA Warning Letters Week of 12/8/2019: CAPAs, Complaints, and Quality Systems

December 17, 2019

Enforcement

FDA Warning Letters Week of 12/1/2019: Cell and Tissue Therapies

December 10, 2019